Health ❯Healthcare ❯Pharmaceuticals

Drug Safety

Mifepristone Counterfeit Drugs Product Recall Product Recalls Semaglutide Recalls Side Effects Drug Recalls Medication Recall Tirzepatide

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

It will be available only to early-stage patients with zero or one ApoE4 allele in a controlled access program pending European Commission approval.

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

FDA Advisers Recommend Against Approval of GSK’s Myeloma Drug Blenrep

FDA Restricts Moderna and Novavax COVID-19 Vaccines to Seniors and Vulnerable Groups

Spain Bans “Nectar del Amor” Supplement After Tests Find Undeclared Sildenafil

NHS Begins Mounjaro Rollout in Primary Care as Regulators Review Safety

MHRA Recalls Two Batches of Prescription Paracetamol for Potential Contamination

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Health Canada Recalls Teva Seasonale Birth Control Over Extra Placebo Pills

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

HHS Orders FDA Review of Abortion Pill Following Controversial Analysis

Abortion Pill Study Fuels Debate Over Safety and Access

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

India Bans 35 Unapproved Fixed-Dose Combination Drugs

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Benadryl Liquid Elixir Recalled Over Child-Resistant Packaging Violation

Marty Makary Faces Scrutiny in Confirmation Hearing for FDA Leadership

NHS England Faces Concerns Over MS Drug Switch After Reports of Severe Side Effects

Costco Recalls Cold Medicine Over Contamination Concerns

FDA Recalls Over 233,000 Bottles of Antidepressant Duloxetine for Cancer-Causing Impurity